JPS59102161A - 逆受身凝集反応による抗原検出用試薬 - Google Patents
逆受身凝集反応による抗原検出用試薬Info
- Publication number
- JPS59102161A JPS59102161A JP21317882A JP21317882A JPS59102161A JP S59102161 A JPS59102161 A JP S59102161A JP 21317882 A JP21317882 A JP 21317882A JP 21317882 A JP21317882 A JP 21317882A JP S59102161 A JPS59102161 A JP S59102161A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- serum
- treated
- item
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 42
- 102000036639 antigens Human genes 0.000 title claims abstract description 42
- 108091007433 antigens Proteins 0.000 title claims abstract description 42
- 230000004520 agglutination Effects 0.000 title claims abstract description 40
- 238000001514 detection method Methods 0.000 title claims abstract description 31
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 18
- 239000000243 solution Substances 0.000 claims abstract description 162
- 210000002966 serum Anatomy 0.000 claims abstract description 71
- 102000005686 Serum Globulins Human genes 0.000 claims abstract description 36
- 108010045362 Serum Globulins Proteins 0.000 claims abstract description 36
- 239000012266 salt solution Substances 0.000 claims abstract description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004202 carbamide Substances 0.000 claims abstract description 6
- 229910002651 NO3 Inorganic materials 0.000 claims abstract description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims abstract description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims abstract 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 119
- 238000007259 addition reaction Methods 0.000 claims description 10
- 239000012895 dilution Substances 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- -1 alkaline earth metal salt Chemical class 0.000 claims description 3
- LQFBACQDOOBRFT-UHFFFAOYSA-N acetic acid;thiocyanic acid Chemical compound SC#N.CC(O)=O LQFBACQDOOBRFT-UHFFFAOYSA-N 0.000 claims description 2
- 229910001514 alkali metal chloride Inorganic materials 0.000 claims description 2
- 229910001617 alkaline earth metal chloride Inorganic materials 0.000 claims description 2
- 239000011260 aqueous acid Substances 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 abstract description 19
- 210000000601 blood cell Anatomy 0.000 abstract description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 6
- 239000000872 buffer Substances 0.000 abstract description 6
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 abstract description 4
- 238000000502 dialysis Methods 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 4
- 229910021538 borax Inorganic materials 0.000 abstract description 3
- 239000004328 sodium tetraborate Substances 0.000 abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 230000015271 coagulation Effects 0.000 abstract 2
- 238000005345 coagulation Methods 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000000337 buffer salt Substances 0.000 abstract 1
- 229960001269 glycine hydrochloride Drugs 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 241000700199 Cavia porcellus Species 0.000 description 29
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 26
- 238000011282 treatment Methods 0.000 description 14
- 229910001629 magnesium chloride Inorganic materials 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000004816 latex Substances 0.000 description 9
- 229920000126 latex Polymers 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 206010029719 Nonspecific reaction Diseases 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 102000006395 Globulins Human genes 0.000 description 7
- 108010044091 Globulins Proteins 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 5
- 230000035931 haemagglutination Effects 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- 230000008313 sensitization Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001494479 Pecora Species 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- SPJOZZSIXXJYBT-UHFFFAOYSA-N Fenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 SPJOZZSIXXJYBT-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ALWXETURCOIGIZ-UHFFFAOYSA-N 1-nitropropylbenzene Chemical compound CCC([N+]([O-])=O)C1=CC=CC=C1 ALWXETURCOIGIZ-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019776 Hepatitis H Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101000903060 Mus musculus DnaJ homolog subfamily C member 7 Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101000827791 Sus scrofa Alpha-fetoprotein Proteins 0.000 description 1
- 101000942123 Sus scrofa C-reactive protein Proteins 0.000 description 1
- 101100275794 Sus scrofa CRP gene Proteins 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- ZJZXSOKJEJFHCP-UHFFFAOYSA-M lithium;thiocyanate Chemical compound [Li+].[S-]C#N ZJZXSOKJEJFHCP-UHFFFAOYSA-M 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- SXTGAOTXVOMSFW-UHFFFAOYSA-L magnesium;dithiocyanate Chemical compound [Mg+2].[S-]C#N.[S-]C#N SXTGAOTXVOMSFW-UHFFFAOYSA-L 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000005121 nitriding Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QXADHXQCAQTNGW-UHFFFAOYSA-M sodium;boric acid;hydroxide Chemical compound [OH-].[Na+].OB(O)O QXADHXQCAQTNGW-UHFFFAOYSA-M 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21317882A JPS59102161A (ja) | 1982-12-03 | 1982-12-03 | 逆受身凝集反応による抗原検出用試薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21317882A JPS59102161A (ja) | 1982-12-03 | 1982-12-03 | 逆受身凝集反応による抗原検出用試薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59102161A true JPS59102161A (ja) | 1984-06-13 |
| JPH0230667B2 JPH0230667B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-07-09 |
Family
ID=16634830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21317882A Granted JPS59102161A (ja) | 1982-12-03 | 1982-12-03 | 逆受身凝集反応による抗原検出用試薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59102161A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63106560A (ja) * | 1986-10-23 | 1988-05-11 | Etsuko Kakizaki | 抗原又は抗体含有微細多孔性フイルム |
| JPS6444855A (en) * | 1987-07-31 | 1989-02-17 | Boehringer Mannheim Gmbh | Removal of non-specific turbidity |
| JPS6474452A (en) * | 1987-09-17 | 1989-03-20 | Tokuyama Soda Kk | Reagent sealing body |
| WO1990008320A1 (fr) * | 1989-01-19 | 1990-07-26 | Teijin Limited | Procede, reactifs et kits d'analyse immunologique |
| JPH05502904A (ja) * | 1989-01-19 | 1993-05-20 | エデュラン アクティー ゼルスカブ | 断熱発泡プラスチック材料の製造方法およびこの方法に用いる発泡剤 |
| EP2241886A1 (en) * | 2009-04-15 | 2010-10-20 | Beckman Coulter Biomedical Limited | Homogeneous agglutination immunoassay method and kit for such method |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5512419A (en) * | 1978-07-13 | 1980-01-29 | Teikoku Hormone Mfg Co Ltd | Immunological measurement and reagent therefor |
| JPS5598359A (en) * | 1978-12-22 | 1980-07-26 | Amano Pharmaceut Co Ltd | Removing method of non-characteristic obstacle operation in immunity determination method |
| JPS562555A (en) * | 1979-06-22 | 1981-01-12 | Green Cross Corp:The | Aqueous solvent for cohesion test |
| JPS56158947A (en) * | 1980-04-15 | 1981-12-08 | Technicon Instr | Coagulation reaction immunologic inspection |
| JPS5735754A (en) * | 1980-08-13 | 1982-02-26 | Toray Ind Inc | Immunological inspecting method |
-
1982
- 1982-12-03 JP JP21317882A patent/JPS59102161A/ja active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5512419A (en) * | 1978-07-13 | 1980-01-29 | Teikoku Hormone Mfg Co Ltd | Immunological measurement and reagent therefor |
| JPS5598359A (en) * | 1978-12-22 | 1980-07-26 | Amano Pharmaceut Co Ltd | Removing method of non-characteristic obstacle operation in immunity determination method |
| JPS562555A (en) * | 1979-06-22 | 1981-01-12 | Green Cross Corp:The | Aqueous solvent for cohesion test |
| JPS56158947A (en) * | 1980-04-15 | 1981-12-08 | Technicon Instr | Coagulation reaction immunologic inspection |
| JPS5735754A (en) * | 1980-08-13 | 1982-02-26 | Toray Ind Inc | Immunological inspecting method |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63106560A (ja) * | 1986-10-23 | 1988-05-11 | Etsuko Kakizaki | 抗原又は抗体含有微細多孔性フイルム |
| JPS6444855A (en) * | 1987-07-31 | 1989-02-17 | Boehringer Mannheim Gmbh | Removal of non-specific turbidity |
| JPS6474452A (en) * | 1987-09-17 | 1989-03-20 | Tokuyama Soda Kk | Reagent sealing body |
| WO1990008320A1 (fr) * | 1989-01-19 | 1990-07-26 | Teijin Limited | Procede, reactifs et kits d'analyse immunologique |
| JPH05502904A (ja) * | 1989-01-19 | 1993-05-20 | エデュラン アクティー ゼルスカブ | 断熱発泡プラスチック材料の製造方法およびこの方法に用いる発泡剤 |
| EP2241886A1 (en) * | 2009-04-15 | 2010-10-20 | Beckman Coulter Biomedical Limited | Homogeneous agglutination immunoassay method and kit for such method |
| WO2010118861A1 (en) * | 2009-04-15 | 2010-10-21 | Beckman Coulter Biomedical Limited | Homogeneous agglutination immunoassay method and kit for such method |
| CN102395885A (zh) * | 2009-04-15 | 2012-03-28 | 贝克曼考尔特生物医学有限公司 | 均相凝集免疫测定方法和用于这种方法的试剂盒 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0230667B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104977404B (zh) | 抑制类风湿因子干扰的胶乳增强免疫比浊试剂 | |
| CN108535491A (zh) | 一种肌钙蛋白i的胶乳增强免疫比浊检测试剂盒 | |
| CA1195925A (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
| CN114324854A (zh) | 复合型生物阻断剂及其制备方法和试剂条 | |
| EP0345277B1 (en) | Analyte detection in particulate-containing samples | |
| JPS58165055A (ja) | 免疫学的ラテツクス凝集法 | |
| JP2000221196A (ja) | 免疫測定方法 | |
| JPS59102161A (ja) | 逆受身凝集反応による抗原検出用試薬 | |
| JPH01129163A (ja) | アポリポタンパク質ｂの診断試薬および測定法 | |
| US5466611A (en) | Method for the determination of antigens or antibodies in the presence of an immune complex | |
| JPH02257063A (ja) | 免疫測定試薬および免疫測定法 | |
| JP6931673B2 (ja) | 免疫分析方法及び試薬 | |
| JPS6022295B2 (ja) | 赤血球凝集試験用水性溶媒 | |
| WO2017090103A1 (ja) | 免疫分析方法及び試薬キット | |
| JP2649016B2 (ja) | 免疫反応干渉作用の除去方法 | |
| JP4278123B2 (ja) | 免疫学的測定方法、免疫反応干渉物質の除去方法および測定試薬 | |
| JPH0799372B2 (ja) | 逆受身凝集反応用非特異反応吸収剤 | |
| JPH04329357A (ja) | 免疫学的測定方法 | |
| JPH08327629A (ja) | 検体前処理方法 | |
| JP2684425B2 (ja) | ラテックス試薬 | |
| JPS6229746B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPH0456258B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JP2704760B2 (ja) | 凝集抗体 | |
| JPS60364A (ja) | 新規な抗原定量法 | |
| JPS62257060A (ja) | 赤血球溶血反応試薬 |